Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA accepts regulatory submission for Novartis biosimilar

November 18, 2015 Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim

Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …
News

UCB appoints Steve Turley as MD for Britain and Ireland

November 18, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB

Steve Turley has joined UCB as the company’s managing director for the British and Irish isles, moving from Lundbeck. He …
Appointment

DJM PAN Unlimited adds client services director

November 17, 2015 Manufacturing and Production, Sales and Marketing

Wyndham Clark has joined the board of DJM PAN Unlimited as client services director. Previously, Clark was client services director …
Appointment

NICE rejects Roche’s Kadcyla for NHS; price still too high

November 17, 2015 Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche

NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …
News

FDA approves Baxalta Haemophilia A treatment

November 16, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
News

Former Health Secretary Andrew Lansley takes on Roche advisory role

November 16, 2015 Medical Communications, Sales and Marketing

Former UK health secretary Andrew Lansley has taken on work as an advisor to Roche in the midst of ongoing …
News

Novo Nordisk invests $20m in diabetes research following study

November 16, 2015 Research and Development, Sales and Marketing

Novo Nordisk has unveiled plans to combat urban diabetes in a $20 million investment offering expert resources and research funds …
News

Amgen’s Humira biosimilar succeeds in Phase III arthritis study

November 16, 2015 Research and Development, Sales and Marketing Amgen, Humira

Amgen says its Humira (adalimumab) biosimilar candidate ABP 501 proved its clinical equivalence to Abbvie’s blockbuster drug in a head-to-head …
News

Takeda UK strengthens its senior leadership team

November 16, 2015 Medical Communications, Sales and Marketing

Takeda UK is bolstering its Medical and Human Resources functions as Takeda continues to develop its expertise in the Specialty …
Appointment

Perrigo rejects $26 billion hostile Mylan takeover bid

November 13, 2015 Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions

Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …
News

FDA expands Gilead’s Harvoni indications for Hep C

November 13, 2015 Sales and Marketing Gilead, Gilead Sciences, harvoni, ledipasvir-sofosbuvir

Gilead’s Harvoni has been approved by the FDA for expanded use in patients with genotypes 4, 5 and 6 chronic …
News

New appointments for AstraZeneca’s Mene Pangalos

November 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …
Appointment

Three new drugs approved for use in Scotland

November 12, 2015 Sales and Marketing Scottish Medicines Consortium

The Scottish Medicines Consortium (SMC) has given the go-ahead for the use of several drugs on the NHS in Scotland. …
News

GSK ready for lupus drug push

November 12, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …
News

Merck achieves 7% sales growth in Q3 2015

November 12, 2015 Sales and Marketing Merck, Rebif, financial results

German pharma group Merck has earned a 7% bump in its sales, and a 10% boost in earnings before deductions, …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026